Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Muller & Phipps (India)BOM:501477 -0.38%59 Days Inventory is 27.69 as of Mar. 2026, which is 10% above its 10-year median of 25.19. GuruFocus rates BOM:501477 with a GF Score™ of 59/100 and a GF Value™ of ₹282.10 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 496 Healthcare Providers & Services companies, Muller & Phipps (India) ranks better than 53.23% on this metric.
The historical rank and industry rank for Muller & Phipps (India)'s Days Inventory or its related term are showing as below:
BOM:501477'
s Days Inventory Range Over the Past 10 Years
Min: 5.78 Med: 25.19 Max: 38.52
Current: 26.83
During the past 13 years, Muller & Phipps (India)'s highest Days Inventory was 38.52. The lowest was 5.78. And the median was 25.19.
BOM:501477's Days Inventory is ranked better than 53.23% of 496
companies
in the Healthcare Providers & Services industry
Industry Median: 29.56
vs BOM:501477: 26.83
Inventory Turnover measures how fast the company turns over its inventory within a year.
Muller & Phipps (India)'s Inventory Turnover for the
three
months ended in Mar. 2026 was 3.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Muller & Phipps (India)'s Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.11.
Muller & Phipps (India) (BOM:501477) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Muller & Phipps (India)'s Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Muller & Phipps (India)'s Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Muller & Phipps (India) Days Inventory Related Terms
Muller & Phipps (India) Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Muller & Phipps (India) Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Muller & Phipps (India)'s Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Muller & Phipps (India) Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Muller & Phipps (India)'s Days Inventory distribution charts can be found below:
* The bar in red indicates where Muller & Phipps (India)'s Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Muller & Phipps (India) (BOM:501477) has a Days Inventory of 27.69 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Muller & Phipps (India) and its competitors. This is 10% above median its historical median of 25.19. Over the past decade, Muller & Phipps (India)'s Days Inventory has ranged from 5.78 to 38.52. According to the industry distribution chart, Muller & Phipps (India) ranks #232 out of 496 companies in the Healthcare Providers & Services industry, placing it in the top 46.8%.
Is Muller & Phipps (India)'s Days Inventory too high?
Muller & Phipps (India)'s current Days Inventory of 27.69 is 10% above median its 10-year median of 25.19. Over the past 10 years, this metric has ranged from a low of 5.78 to a high of 38.52. The Healthcare Providers & Services industry median Days Inventory is 29.56. Muller & Phipps (India)'s value of 27.69 is 6.3% below this industry median. Based on the distribution chart, Muller & Phipps (India) ranks #232 out of 496 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Muller & Phipps (India) has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Muller & Phipps (India)'s Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Muller & Phipps (India) ranks #232 out of 496 companies for Days Inventory. This puts Muller & Phipps (India) in the upper half of its industry. The industry median Days Inventory is 29.56. Muller & Phipps (India)'s value of 27.69 is 6.3% below this benchmark. Historically, Muller & Phipps (India)'s own Days Inventory has ranged from 5.78 to 38.52 over the past decade. While the company's 10-year median is 25.19 vs. the industry median of 29.56, Muller & Phipps (India) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.56, based on 496 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Muller & Phipps (India)'s current Days Inventory of 27.69 is 6.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Muller & Phipps (India) and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Muller & Phipps (India)'s current Days Inventory is 27.69, which is 10% above median its own 10-year median of 25.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Muller & Phipps (India) stock overvalued right now?
Based on GuruFocus' analysis, Muller & Phipps (India) (BOM:501477) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹282.10, compared to a current price of ₹212.00 — trading 24.8% below its estimated fair value. The current Days Inventory is 27.69, which is 10% above median its 10-year median of 25.19 and 6.3% below the Healthcare Providers & Services industry median of 29.56. Muller & Phipps (India)'s overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Muller & Phipps (India) (BOM:501477), the current Days Inventory is 27.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Muller & Phipps (India) (BOM:501477) Overvalued in 2026?
Based on GuruFocus' analysis, Muller & Phipps (India) stock appears to be undervalued.
The current stock price of ₹212.00 is trading 24.8% below its estimated GF Value™ of ₹282.10.
GuruFocus considers Muller & Phipps (India) to be Modestly Undervalued.
Key valuation signals for BOM:501477:
Days Inventory: 27.69 (10% above median its 10-year median of 25.19)
GF Value™: ₹282.10 vs. price of ₹212.00 (24.8% below fair value)
Industry Position: 6.3% below the Healthcare Providers & Services median (#232 of 496)
No single metric tells the full story. See the BOM:501477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparations and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, Food Products, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment, and home care products. Its brand names include Cavisan, Cavidine, and Nixoderm.
59GF Score
Get the complete analysis for BOM:501477
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:501477 has been successfully added to your 
